The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells - PubMed (original) (raw)
. 2004 Dec 2;432(7017):635-9.
doi: 10.1038/nature03147.
Affiliations
- PMID: 15577913
- DOI: 10.1038/nature03147
Free article
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
Ryan T Phan et al. Nature. 2004.
Free article
Abstract
The human proto-oncogene BCL6 encodes a BTB/POZ-zinc-finger transcriptional repressor that is necessary for germinal-centre formation and is implicated in the pathogenesis of B-cell lymphoma. The precise function of BCL6 in germinal-centre development and lymphomagenesis is unclear because very few direct BCL6 target genes have been identified. Here we report that BCL6 suppresses the expression of the p53 (also known as tp53) tumour suppressor gene and modulates DNA damage-induced apoptotic responses in germinal-centre B cells. BCL6 represses p53 transcription by binding two specific DNA sites within the p53 promoter region and, accordingly, p53 expression is absent in germinal-centre B cells where BCL6 is highly expressed. Suppression of BCL6 expression via specific short interfering RNA leads to increased levels of p53 messenger RNA and protein both under basal conditions and in response to DNA damage. Most notably, constitutive expression of BCL6 protects B cell lines from apoptosis induced by DNA damage. These results suggest that an important function of BCL6 is to allow germinal-centre B cells to tolerate the physiological DNA breaks required for immunoglobulin class switch recombination and somatic hypermutation without inducing a p53-dependent apoptotic response. These findings also imply that deregulated BCL6 expression contributes to lymphomagenesis in part by functional inactivation of p53.
Similar articles
- Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR, Gu W, Dalla-Favera R. Bereshchenko OR, et al. Nat Genet. 2002 Dec;32(4):606-13. doi: 10.1038/ng1018. Epub 2002 Oct 28. Nat Genet. 2002. PMID: 12402037 - BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. Phan RT, et al. Nat Immunol. 2005 Oct;6(10):1054-60. doi: 10.1038/ni1245. Epub 2005 Sep 4. Nat Immunol. 2005. PMID: 16142238 - PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J. Torlakovic E, et al. J Pathol. 2005 Jul;206(3):312-9. doi: 10.1002/path.1777. J Pathol. 2005. PMID: 15892171 - The proto-oncogene BCL-6 in normal and malignant B cell development.
Niu H. Niu H. Hematol Oncol. 2002 Dec;20(4):155-66. doi: 10.1002/hon.689. Hematol Oncol. 2002. PMID: 12469325 Review. - Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F, Sahota SS. Jardin F, et al. Hematology. 2005 Apr;10(2):115-29. doi: 10.1080/10245330400026105. Hematology. 2005. PMID: 16019457 Review.
Cited by
- B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.
Weniger MA, Seifert M, Küppers R. Weniger MA, et al. Methods Mol Biol. 2025;2865:1-30. doi: 10.1007/978-1-0716-4188-0_1. Methods Mol Biol. 2025. PMID: 39424718 Review. - Centrioles are frequently amplified in early B cell development but dispensable for humoral immunity.
Schapfl MA, LoMastro GM, Braun VZ, Hirai M, Levine MS, Kiermaier E, Labi V, Holland AJ, Villunger A. Schapfl MA, et al. Nat Commun. 2024 Oct 15;15(1):8890. doi: 10.1038/s41467-024-53222-4. Nat Commun. 2024. PMID: 39406735 Free PMC article. - Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.
Malyukova A, Lahnalampi M, Falqués-Costa T, Pölönen P, Sipola M, Mehtonen J, Teppo S, Akopyan K, Viiliainen J, Lohi O, Hagström-Andersson AK, Heinäniemi M, Sangfelt O. Malyukova A, et al. Genome Biol. 2024 May 31;25(1):143. doi: 10.1186/s13059-024-03260-4. Genome Biol. 2024. PMID: 38822412 Free PMC article. - Selective deletion of E3 ubiquitin ligase FBW7 in VE-cadherin-positive cells instigates diffuse large B-cell lymphoma in mice in vivo.
Cai Z, You S, Liu Z, Song P, Zhao F, An J, Ding Y, He B, Zou MH. Cai Z, et al. Cell Death Dis. 2024 Mar 14;15(3):212. doi: 10.1038/s41419-024-06597-7. Cell Death Dis. 2024. PMID: 38485719 Free PMC article. - Delineating the mechanism of fragility at BCL6 breakpoint region associated with translocations in diffuse large B cell lymphoma.
Gopalakrishnan V, Roy U, Srivastava S, Kariya KM, Sharma S, Javedakar SM, Choudhary B, Raghavan SC. Gopalakrishnan V, et al. Cell Mol Life Sci. 2024 Jan 10;81(1):21. doi: 10.1007/s00018-023-05042-w. Cell Mol Life Sci. 2024. PMID: 38196006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous